文献速递肾癌与肾肿瘤

新型评分系统量化减少良性肾肿瘤手术的机会:MUSIC-KIDNEY协作组回顾性质量改进分析

Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY Collaborative.
PubMed 文献 · J Urol · 2020-07-06

该研究基于MUSIC-KIDNEY协作组数据,回顾性分析cT1肾肿块因非恶性病理接受手术的病例,由5名肾外科医生独立评估质量改进机会。结果显示74例(11%)为非恶性病理,约半数存在中度或重大改进机会,根治性肾切除术是最常见原因,并指出可达到的最低和可接受非恶性病理率分别为1.9%和5.4%。

要点

  • cT1肾肿块手术后非恶性病理占11%,其中31%为cT1b。
  • 提高重复影像、肾肿块活检和监测使用可减少不必要干预。

核心结论

  • cT1肾肿块因非恶性病理手术的病例中约半数存在中度或重大质量改进机会。
  • 根治性肾切除术用于非恶性病理是最常见的改进原因。
  • 非恶性病理的最低可达到率和可接受率分别为1.9%和5.4%。

研究设计与样本

  • MUSIC-KIDNEY协作组回顾性质量改进分析,自2017年开始收集数据。
  • 纳入cT1肾肿块接受部分或根治性肾切除术且病理为非恶性的患者。
  • 由5名经验丰富的肾外科医生独立对每例分配改进类别(无-0、轻微-1、中度-2、重大-3)。

主要发现

  • 1392例cT1肾肿块患者中653例接受手术,74例(11%)为非恶性病理。
  • 74例中23例(31%)为cT1b;17例(22.9%)行根治性肾切除术(5例cT1a,12例cT1b)。
  • 仅6例术前接受活检(5例嗜酸细胞瘤,1例未分类肾细胞癌)。
  • 质量改进机会:轻微25例(34%)、中度26例(35%)、重大10例(14%),17%无改进机会(12例部分肾切除,1例根治性肾切除)。

关键数值与推荐

  • 非恶性病理最低可达到率为1.9%,可接受率为5.4%。

临床怎么用

  • 应更多使用重复影像、肾肿块活检和监测以避免对非恶性病理的干预。
  • 尤其应避免对非恶性病理行根治性肾切除术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Nonmalignant pathology has been reported in 15% to 20% of surgeries for cT1 renal masses. We seek to identify opportunities for improvement in avoiding surgery for nonmalignant pathology. MATERIALS AND METHODS: MUSIC-KIDNEY started collecting data in 2017. All patients with cT1 renal masses who had partial or radical nephrectomy for nonmalignant pathology were identified. Category for improvement (none-0, minor-1, moderate-2 or major-3) was independently assigned to each case by 5 experienced kidney surgeons. Specific strategies to decrease nonmalignant pathology were identified. RESULTS: Of 1,392 patients with cT1 renal masses 653 underwent surgery and 74 had nonmalignant pathology (11%). Of these, 23 (31%) cases were cT1b. Radical nephrectomy was performed in 17 (22.9%) patients for 5 cT1a and 12 cT1b lesions. Only 6 patients had a biopsy prior to surgery (5 oncocytoma, 1 unclassified renal cell carcinoma). Review identified 25 cases with minor (34%), 26 with moderate (35%) and 10 with major (14%) quality improvement opportunities. Overall 17% of cases had no quality improvement opportunities identified (12 partial nephrectomy, 1 radical nephrectomy). CONCLUSIONS: Review of patients with cT1 renal masses who underwent surgery for nonmalignant pathology revealed a significant number of cases in which this outcome may have been avoided. Approximately half of cases had moderate or major quality improvement opportunities, with radical nephrectomy for nonmalignant pathology being the most common reason. Our data indicate a lowest achievable and acceptable rate of nonmalignant pathology to be 1.9% and 5.4%, respectively. Avoiding interventions for nonmalignant pathology, particularly radical nephrectomy, is an important focus of quality improvement efforts. Strategies to decrease unnecessary interventions for nonmalignant pathology include greater use of repeat imaging, renal mass biopsy and surveillance.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Peabody H, Patel A, Johnson A, et al. Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY Collaborative. J Urol. 2020. PMID: 32628102. doi:10.1097/JU.0000000000001238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。